Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Current neuropharmacology

Showing results (1-10 of 1,957) with videos related to

Pageof 196
Sort By:
Current Neuropharmacology|June 2, 2010
Mmp-9, a potential target for cerebral ischemic treatmentXue Dong, Yu-Ning Song, Wei-Guo Liu, et al.
Current Neuropharmacology|June 2, 2010
Mechanisms of action of antipsychotic drugs of different classes, refractoriness to therapeutic effects of classical neuroleptics, and individual variation in sensitivity to their actions: Part IR Miller
Current Neuropharmacology|June 2, 2010
Serotonin-norepinephrine reuptake inhibitors for pain control: premise and promiseDavid M Marks, Manan J Shah, Ashwin A Patkar, et al.
Current Neuropharmacology|September 3, 2010
Past, present and future therapeutics for cerebellar ataxiasD Marmolino, M Manto
Current Neuropharmacology|September 3, 2010
Cyclooxygenase and neuroinflammation in Parkinson's disease neurodegenerationAnna L Bartels, Klaus L Leenders
Current Neuropharmacology|December 2, 2010
Aquaporins and gliaRoberta Albertini, Rossella Bianchi
Current Neuropharmacology|December 2, 2010
Aquaporin and vascular diseasesCarla Loreto, Ester Reggio
Current Neuropharmacology|December 2, 2010
Clinical and pharmacological aspects of inflammatory demyelinating diseases in childhood: an updateAlberto Spalice, Pasquale Parisi, Laura Papetti, et al.
Current Neuropharmacology|December 2, 2010
Winning a won game: caffeine panacea for obesity syndemicM Myslobodsky, A Eldan
Current Neuropharmacology|August 9, 2016
Erratum: Methylphenidate on Cognitive Improvement in Patients with Traumatic Brain Injury: A Meta-Analysis
Pageof 196

Showing results (1-10 of 1,957) with videos related to

Sort By:
Pageof 196
Current Neuropharmacology|June 2, 2010
Mmp-9, a potential target for cerebral ischemic treatmentXue Dong, Yu-Ning Song, Wei-Guo Liu, et al.
Current Neuropharmacology|June 2, 2010
Mechanisms of action of antipsychotic drugs of different classes, refractoriness to therapeutic effects of classical neuroleptics, and individual variation in sensitivity to their actions: Part IR Miller
Current Neuropharmacology|June 2, 2010
Serotonin-norepinephrine reuptake inhibitors for pain control: premise and promiseDavid M Marks, Manan J Shah, Ashwin A Patkar, et al.
Current Neuropharmacology|September 3, 2010
Past, present and future therapeutics for cerebellar ataxiasD Marmolino, M Manto
Current Neuropharmacology|September 3, 2010
Cyclooxygenase and neuroinflammation in Parkinson's disease neurodegenerationAnna L Bartels, Klaus L Leenders
Current Neuropharmacology|December 2, 2010
Aquaporins and gliaRoberta Albertini, Rossella Bianchi
Current Neuropharmacology|December 2, 2010
Aquaporin and vascular diseasesCarla Loreto, Ester Reggio
Current Neuropharmacology|December 2, 2010
Clinical and pharmacological aspects of inflammatory demyelinating diseases in childhood: an updateAlberto Spalice, Pasquale Parisi, Laura Papetti, et al.
Current Neuropharmacology|December 2, 2010
Winning a won game: caffeine panacea for obesity syndemicM Myslobodsky, A Eldan
Current Neuropharmacology|August 9, 2016
Erratum: Methylphenidate on Cognitive Improvement in Patients with Traumatic Brain Injury: A Meta-Analysis
Pageof 196